Percent viability and cytotoxicity of NHBE cells are significantly altered by PAA exposure. by Ellie S. Burns (21246537)

“…Percent viability significantly decreased with PAA concentration and between recovery times compared to controls. …”

Evaluation of chronic <i>in vivo</i> efficacy in 21 days rat MCT model in prevention mode. by Tobias G. Schips (21799838)

Evaluation of chronic <i>in vivo</i> efficacy in 21 days rat MCT model in prevention mode. by Tobias G. Schips (21799838)

The effects of CGA on NLRP3 inflammasome and the Nrf2 pathway in HK-2 cells. by Liping Bao (2936715)

Photographs of strain VROV1 isolated from marine sediments collected on the northern Central Indian Ridge. by Bokyung Kim (622579)

Subgroup Meta Analysis for HE Incidence Based on Treatment Duration and Dose. by Yangyang Hu (3309009)

The effects of CGA on NLRP3 inflammasome and the Nrf2 pathway in high-fat diet (HFD)/ streptozotocin (STZ) -induced diabetic kidneys. by Liping Bao (2936715)

Calycosin Inhibit PANoptosis and Alleviate Brain Damage: A Bioinformatics and Experimental Verification Approach by Huiyan An (20959966)

“…Numerous studies have highlighted the significance of PANoptosis in brain ischemia–reperfusion (I/R) injury. …”

The mRNA (A) and protein (B) levels of <i>NlPHB2</i> in viruliferous and nonviruliferous <i>N. lugens</i> determined by RT-qPCR and Western blot assays at 6 dpvf. by Lianshun Zheng (22086585)

Basic characteristics of the studies included. by Renáta Kiss-Miki (20760127)

“…The 5-year overall survival results showed statistically no significant difference between the two radiotherapy modalities (OR = 0.80, 95% CI: 0.51–1.23, <i>p</i> = 0.22, <i>I</i>^<i>2</i> = 0%). …”

List_of_studies_identified_31-JAN-2025. by Renáta Kiss-Miki (20760127)

“…The 5-year overall survival results showed statistically no significant difference between the two radiotherapy modalities (OR = 0.80, 95% CI: 0.51–1.23, <i>p</i> = 0.22, <i>I</i>^<i>2</i> = 0%). …”

Data_extraction_table_31-JAN-2025. by Renáta Kiss-Miki (20760127)

“…The 5-year overall survival results showed statistically no significant difference between the two radiotherapy modalities (OR = 0.80, 95% CI: 0.51–1.23, <i>p</i> = 0.22, <i>I</i>^<i>2</i> = 0%). …”

Imaging CDK4/6 Broaden Options of Breast Cancer Diagnostics with Positron Emission Tomography by Mengjing Ji (17741338)

“…Two CDK4/6-targeting precursors were synthesized and evaluated <i>in vitro</i> and <i>in vivo</i>. Three breast cancer cell linesMCF-7, MDA-MB-231, and MDA-MB-468were selected based on decreasing sensitivity to palbociclib. …”

Imaging CDK4/6 Broaden Options of Breast Cancer Diagnostics with Positron Emission Tomography by Mengjing Ji (17741338)

“…Two CDK4/6-targeting precursors were synthesized and evaluated <i>in vitro</i> and <i>in vivo</i>. Three breast cancer cell linesMCF-7, MDA-MB-231, and MDA-MB-468were selected based on decreasing sensitivity to palbociclib. …”

Imaging CDK4/6 Broaden Options of Breast Cancer Diagnostics with Positron Emission Tomography by Mengjing Ji (17741338)

“…Two CDK4/6-targeting precursors were synthesized and evaluated <i>in vitro</i> and <i>in vivo</i>. Three breast cancer cell linesMCF-7, MDA-MB-231, and MDA-MB-468were selected based on decreasing sensitivity to palbociclib. …”

Imaging CDK4/6 Broaden Options of Breast Cancer Diagnostics with Positron Emission Tomography by Mengjing Ji (17741338)

“…Two CDK4/6-targeting precursors were synthesized and evaluated <i>in vitro</i> and <i>in vivo</i>. Three breast cancer cell linesMCF-7, MDA-MB-231, and MDA-MB-468were selected based on decreasing sensitivity to palbociclib. …”

Imaging CDK4/6 Broaden Options of Breast Cancer Diagnostics with Positron Emission Tomography by Mengjing Ji (17741338)

“…Two CDK4/6-targeting precursors were synthesized and evaluated <i>in vitro</i> and <i>in vivo</i>. Three breast cancer cell linesMCF-7, MDA-MB-231, and MDA-MB-468were selected based on decreasing sensitivity to palbociclib. …”

Imaging CDK4/6 Broaden Options of Breast Cancer Diagnostics with Positron Emission Tomography by Mengjing Ji (17741338)

“…Two CDK4/6-targeting precursors were synthesized and evaluated <i>in vitro</i> and <i>in vivo</i>. Three breast cancer cell linesMCF-7, MDA-MB-231, and MDA-MB-468were selected based on decreasing sensitivity to palbociclib. …”

Imaging CDK4/6 Broaden Options of Breast Cancer Diagnostics with Positron Emission Tomography by Mengjing Ji (17741338)

“…Two CDK4/6-targeting precursors were synthesized and evaluated <i>in vitro</i> and <i>in vivo</i>. Three breast cancer cell linesMCF-7, MDA-MB-231, and MDA-MB-468were selected based on decreasing sensitivity to palbociclib. …”

HL-IR is crucial for ticks to recognize cinnamaldehyde. by Ceyan Kuang (8554557)